" class="no-js "lang="en-US"> Javier Rodriguez - Medtech Alert
Friday, March 29, 2024
Javier Rodriguez

Javier Rodriguez

About Javier Rodriguez

In more than 20 years with DaVita, I have built on my experience as a leader committed to transforming care delivery for patients with kidney disease – from the earliest stages through transplantation. I’m passionate about accelerating the digital transformation and delivering customized care to each patient while lowering costs for the health care system. All of us at DaVita strive to improve the quality of life for our patients through clinical innovation and integrated, personalized care.

I have experienced firsthand the importance and impact of fostering a powerful sense of belonging and community among teammates and patients. In 2020, I became one of 550 CEOs to sign the CEO Action Pledge for Diversity & Inclusion. I proudly sit on the board of directors for Gilead Sciences Inc.

Related Story

Medtronic and DaVita Announce New Kidney Health Technology Company

May 30 2022

Medtronic plc (NYSE:MDT) and DaVita Inc. (NYSE:DVA) today announced the intent to form a new, independent kidney care-focused […]

DaVita Acquires MedSleuth, Deepens Efforts to Improve Transplant Experience

January 18 2022

DaVita Inc. today announced its acquisition of transplant software company MedSleuth. Working with transplant centers across […]